Compare Immunovant Inc. Common Stock (IMVT) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs ProShares UltraPro Short QQQ ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while ProShares UltraPro Short QQQ ETF trades at $32.66 (market cap $2.23B). The key difference: Immunovant Inc. Common Stock is far larger — about 2.8× ProShares UltraPro Short QQQ ETF's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| IMVT | SQQQ | |
|---|---|---|
Market Cap | $6.25B | $2.23B |
Volume | 1,755,411 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $44.96 | $89.43 |
52-Week Low | $17.03 | $31.83 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $5.35B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SQQQ (ProShares UltraPro Short QQQ) trades at $32.08, up 0.79% today, as a 3x leveraged inverse ETF designed to profit from declines in the Nasdaq-100. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators suggest potential near-term oversold conditions. The ETF serves as a hedging tool against tech sector weakness, with recent news highlighting its strategic use alongside long QQQ positions.
Outlook remains tied to Nasdaq-100 performance; further tech sector declines could benefit SQQQ, but leveraged decay and volatility pose significant risks. Investors using SQQQ for hedging should monitor market sentiment and sector-specific catalysts. The ETF's structure makes it unsuitable for long-term holdings due to compounding effects in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
